CLOV vs NERV
Clover Health Investments Corp (CLOV) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
CLOV currently screens at market cap $1.55B. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the CLOV and NERV stock pages for the full models.
Not investment advice.